Persistent Opioid Use and High-Risk Prescribing in Body Contouring Patients.

ABSTRACT:

Background

Opioid misuse occurs commonly among obese patients and after bariatric surgery. However, the risk of new persistent use following postbariatric body contouring procedures remains unknown.

Methods

The authors examined insurance claims from Clinformatics Data Mart (OptumInsight, Eden Prairie, Minn.) between 2001 and 2015 for opioid-naive patients undergoing five body contouring procedures: abdominoplasty/panniculectomy, breast reduction, mastopexy, brachioplasty, and thighplasty (n = 11,257). Their primary outcomes included both new persistent opioid use, defined as continued prescription fills between 90 and 180 days after surgery, and the prevalence of high-risk prescribing. They used multilevel logistic regression to assess the risk of new persistent use, adjusti

SUBMITTER: Bennett KG 

PROVIDER: S-EPMC6311715 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature